drugset / Trial / NCT00665600
Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the efficacy and safety of repeated dosing of Levalbuterol over 6 weeks of treatment in COPD.
Timeline
- Start
- 2002-02
- Primary completion
- 2003-03
- Completion
- 2003-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levalbuterol | Other / unclassified | 0.63 mg | — |
| Subject | Levalbuterol | Other / unclassified | 1.25 mg | — |
| Subject | Salbutamol | Unknown | 2.5 mg | — |